Nektar Therapeutics Azioni (NASDAQ: NKTR)

Nektar Therapeutics

NEKTAR THERAPEUTICS

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Constellation Brands

Pre-Market Outlook

NKTR

PRGS

Una delle aziende sotto i riflettori potrebbe subire un movimento improvviso, trainata dai prossimi annunci finanziari.

Futures USA: una di queste aziende può volare o crollare. Ecco quale

Earnings

Press Releases

Nektar Therapeutics Reports First Quarter 2025 Financial Results

Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Nektar to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin, a Regulatory T-cell Proliferator, in Atopic Dermatitis on June 24, 2025

REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis

Offerings

Nektar Therapeutics Announces Proposed Public Offering

Nektar Therapeutics Announces Pricing of $100 Million Public Offering

Nektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata

Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets

Nektar Therapeutics Reports Second Quarter 2025 Financial Results

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Alumis

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Arvinas

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Evolus

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

Maze Therapeutics

MBX Biosciences

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Omeros

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

scPharmaceuticals

Septerna

SIGA Technologies

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Tvardi Therapeutics

Ventyx Biosciences

Zevra Therapeutics

Zhengye Biotechnology Holding Limited - Ordinary Shares

Comments

Nektar Therapeutics

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO